NCT05931939

Brief Summary

The investigators will study the Ileal interposition to the treatment of weight regain after Roux-en-Y gastric bypass, assessing weight loss, body composition, quality of life, metabolic biomarkers, inflammatory biomarkers, and incretin hormones

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 6, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

April 16, 2024

Status Verified

April 1, 2024

Enrollment Period

2.3 years

First QC Date

May 7, 2023

Last Update Submit

April 14, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes of weight loss of participants after Ileal interposition surgery as measured by weight in kilograms

    Weight loss will be obtained as the difference between preoperative weight and minimum postoperative weight in kilograms

    Change from baseline and after 6 months post-surgery

  • Changes of Health-related quality of life of participants after Ileal interposition surgery as reported by 36-Item Short-Form Health Survey questionnaire

    Health-related quality of life will be assessed using the 36-Item Short-Form Health Survey questionnaire

    Change from Baseline and after 6 months post-surgery

Secondary Outcomes (8)

  • Changes of weight loss of participants after Ileal interposition surgery as measured by weight in kilograms

    Change from baseline and after 3, 6, and 12 months post-surgery

  • Change of body composition of participants after Ileal interposition surgery as measured by lean and fat mass in kilograms

    Change from baseline and after 6 and 12 months post-surgery

  • Change of metabolic profile of participants after Ileal interposition surgery as assessed by serum levels of glucose and insulin

    Change from baseline and after 6 and 12 months post-surgery

  • Change of inflammatory biomarkers and incretin hormones of participants after Ileal interposition surgery as assessed by serum levels of tumor necrosis factor-alpha, interleukin-6, ghrelin, and glucagon-like peptide-1.

    Change from baseline and after 6 months post-surgery

  • Changes in alcohol abuse of participants after Ileal interposition surgery as reported by Alcohol Use Disorders Identification Test

    Change from baseline and after 6 and 12 months post-surgery

  • +3 more secondary outcomes

Study Arms (2)

Ileal Interposition

EXPERIMENTAL

Interposition ileal surgery group Procedure/Surgery: Bariatric surgery

Procedure: Ileal Interposition

Traditional surgical technique

ACTIVE COMPARATOR

Conventional revisional surgery group Procedure/Surgery: Bariatric surgery

Procedure: Traditional surgical technique

Interventions

Bariatric surgery by laparoscopic Ileal Interposition

Ileal Interposition

Bariatric surgery by laparoscopic traditional technique

Traditional surgical technique

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients submitted to initial laparoscopic after initial Roux-en-Y gastric bypass for at least 3 years
  • Loss of excess weight between 60 to 80%
  • Rate of weight regain ≥60%
  • Body mass index ≥ 40 kg/m2 or ≥ 35 kg/m2, with at least 2 comorbidities associated with obesity
  • Present a previous evaluation by the multidisciplinary team with a favorable opinion of the revision surgery.

You may not qualify if:

  • Active chemical dependency on alcohol and/or illicit drugs
  • Severe psychotic or depressive disorder or history of suicide attempts in the last 12 months
  • Eating behavior disorder (uncontrolled)
  • Secondary causes of obesity
  • Pregnancy
  • Severe organ failure
  • Active neoplastic
  • Infectious or inflammatory disease
  • Severe coagulopathy
  • High anesthetic-surgical risk
  • Intellectual inability
  • Lack of preoperative follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

State University of Rio de Janeiro

Rio de Janeiro, Brazil

RECRUITING

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Luiz Guilherme Kraemer-Aguiar, PhD

    State University of Rio de Janeiro

    PRINCIPAL INVESTIGATOR
  • Paulo Roberto G Falcão Leal, MD

    State University of Rio de Janeiro

    PRINCIPAL INVESTIGATOR
  • Karynne G Grutter Lopes, PhD

    State University of Rio de Janeiro

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Luiz Guilherme G Kraemer-Aguiar, PhD

CONTACT

Karynne Grutter Lopes, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, controlled, randomized intervention study, comparing the effect of revisional surgery by laparoscopic Ileal Interposition with traditional surgical technique
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 7, 2023

First Posted

July 6, 2023

Study Start

December 1, 2023

Primary Completion

April 1, 2026

Study Completion

May 1, 2026

Last Updated

April 16, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations